Judge holding gavel in courtroom
by: Jonathan Benson
(NaturalNews) It has been more than five months since an Italian court in Milan awarded compensation to the family of a young boy who developed autism from a six-in-one hexavalent vaccine manufactured bycorrupt British drug giant GlaxoSmithKline(GSK), and the U.S. media is still nowhere to be found in reporting on this breakthrough ruling.
On September 24, 2014, Italy’s version of the National Vaccine Injury Compensation Program agreed that GSK’s “INFANRIX Hexa” vaccine for polio, diphtheria, tetanus, hepatitis B, pertussis and haemophilus influenza type B induced permanent autism and brain damage in the previously healthy child, whose name has been kept private for safety.
The vaccine, which contains multiple antigens, thimerosal (mercury), multiple forms of aluminum, formaldehyde, recombinant (genetically modified) viral components and various chemical preservatives,[PDF] demonstrably caused the young boy to regress…